15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells

15-Lipoxygenase Metabolites of Docosahexaenoic Acid Inhibit Prostate Cancer Cell Proliferation and Survival

(2012) Joseph T. O’Flaherty et al.   PLoS One

5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of  -3 Polyunsaturated Fatty Acids

(2011) P. Sapieha et al.   Science Translational Medicine

Thrombin-activated human platelets acutely generate oxidized docosahexaenoic-acid-containing phospholipids via 12-lipoxygenase

(2010) Lloyd T. Morgan et al.   BIOCHEMICAL JOURNAL

Docosahexanoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line

(2010) Takashi Yamagami et al.   CANCER BIOLOGY & THERAPY

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

(2010) Helena Gleissman et al.   INTERNATIONAL JOURNAL OF CANCER

Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231

(2010) Blanckaert   INTERNATIONAL JOURNAL OF ONCOLOGY

Marine Fatty Acid Intake Is Associated with Breast Cancer Prognosis

(2010) Ruth E. Patterson et al.   JOURNAL OF NUTRITION

Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids

(2010) Rebecca Wall et al.   NUTRITION REVIEWS

Docosahexaenoic Acid Induces Apoptosis in MCF-7 Cells In Vitro and In Vivo via Reactive Oxygen Species Formation and Caspase 8 Activation

(2010) Ki Sung Kang et al.   PLoS One

Old and new generation lipid mediators in acute inflammation and resolution

(2010) Melanie J. Stables et al.   PROGRESS IN LIPID RESEARCH

Angiogenesis Inhibition in Prostate Cancer: Current Uses and Future Promises

(2010) Jeanny B. Aragon-Ching et al.   Journal of Oncology

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

(2009) Philip C. Calder   BIOCHIMIE

Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

(2009) P Bougnoux et al.   BRITISH JOURNAL OF CANCER

The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential

(2009) Laura Spencer et al.   EUROPEAN JOURNAL OF CANCER

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates

(2009) Helena Gleissman et al.   FASEB JOURNAL

Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing

(2009) Yan Lu et al.   JOURNAL OF LIPID RESEARCH

Fatty acids and breast cancer: Sensitization to treatments and prevention of metastatic re-growth

(2009) Philippe Bougnoux et al.   PROGRESS IN LIPID RESEARCH

The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and β-catenin, in prostate cancer

(2009) Hector R. Contreras et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Dietary n-3 Polyunsaturated Fatty Acids Enhance Hormone Ablation Therapy in Androgen-Dependent Prostate Cancer

(2008) Michael F. McEntee et al.   AMERICAN JOURNAL OF PATHOLOGY

Peroxisome Proliferator-Activated Receptor  -Mediated Up-regulation of Syndecan-1 by n-3 Fatty Acids Promotes Apoptosis of Human Breast Cancer Cells

(2008) H. Sun et al.   CANCER RESEARCH

Inflammation and prostate cancer

(2008) Sonya Vasto et al.   Future Oncology

Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: An endoscopy-based case-control study

(2008) Gerda K. Pot et al.   INTERNATIONAL JOURNAL OF CANCER

In Vivoandin VitroRegulation of Syndecan 1 in Prostate Cells byn-3 Polyunsaturated Fatty Acids

(2008) Iris J. Edwards et al.   JOURNAL OF BIOLOGICAL CHEMISTRY